search
Back to results

Amino Acid Infusion in Mothers Before and During Cesarean Delivery

Primary Purpose

Hypothermia

Status
Completed
Phase
Not Applicable
Locations
Nepal
Study Type
Interventional
Intervention
Amino acid solution
Ringer's lactate solution
Sponsored by
B.P. Koirala Institute of Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypothermia focused on measuring amino acid, cesarean delivery, hypothermia

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Parturients belonging to American Society of Anesthesiologists physical status I and II scheduled for elective cesarean delivery were enrolled.

Exclusion Criteria:

  • Pregnancy with fetal distress, intrauterine growth retardation, congenital malformation or premature labor were excluded.

Sites / Locations

  • B P Koirala Institute of Health Sciences

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Amino acid

Ringer's Lactate solution

Arm Description

Intravenous infusion of amino acid solution started approximately one hour prior to spinal anaesthesia after recording the baseline vital parameters. Each patient in experimental group received a total of 200 ml at 2 ml/kg/min.

Intravenous infusion of Ringer's lactate solution started approximately one hour prior to spinal anaesthesia after recording the baseline vital parameters. Each patient in experimental group received a total of 200 ml at 2 ml/kg/min.

Outcomes

Primary Outcome Measures

neonatal rectal temperature
neonatal rectal temperature
neonatal rectal temperature

Secondary Outcome Measures

APGAR score of newborn
number of newborn with adequate suckling reflex
absent or present
scale assessing the discomfort related to cold sensation in mother
0= No perception, 1= Tolerable perception, 2=Intolerable perception
number of mothers who developed shivering
length of hospital stay of mother
length of hospital stay of newborn
change in maternal rectal temperature compared to baseline
maternal rectal temperature
change in maternal rectal temperature compared to baseline
change in maternal rectal temperature compared to baseline
number of neonates who developed shivering

Full Information

First Posted
October 4, 2015
Last Updated
March 14, 2019
Sponsor
B.P. Koirala Institute of Health Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT02575170
Brief Title
Amino Acid Infusion in Mothers Before and During Cesarean Delivery
Official Title
Intravenous Amino Acid Infusion in Mothers Before and During Cesarean Delivery: Effects on Maternal and Neonatal Temperature
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
April 2016 (Actual)
Study Completion Date
April 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
B.P. Koirala Institute of Health Sciences

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Introduction: Intravenous infusion of amino acids during cesarean delivery in mothers and neonates improves neonatal growth. Amino acid before and during anesthesia also prevents hypothermia and associated untoward effects. Method: After ethical approval, this prospective randomized double blind controlled study is being conducted in the university hospital of BPKIHS. Seventy six parturients (ASA 1 & 2) undergoing cesarean delivery without fetal distress, intrauterine growth retardation, congenital malformation or premature labor will be enrolled. For a period starting from approximately one hour prior to spinal anesthesia, Group 1 and Group 2 patients will receive 200 ml of amino acid and lactated ringers solution respectively at 2 ml/kg/hr. The ambient operating room temperature will be maintained near 23º C. No heating methods will be applied apart from covering with a blanket. Primary outcome measure will be neonatal rectal temperature at 0, 5 and 10 min after birth. Secondary outcome measures will be APGAR scores and suckling reflex in the newborn, change in rectal temperature relative to baseline and discomfort related to cold sensation in the mother and the occurrence of shivering both in the mother and newborn.
Detailed Description
Review of literature: Hypothermia is common during peri-operative period (1). It can lead to shivering (2), sympathetic stimulation (3), ischemic cardiac events (3), coagulation disturbances (4,5) delayed recovery from anesthesia (6,7), altered immune system with impaired wound healing (8,9) and prolonged hospitalization (9). Amino acid infusion before and during surgery is known to prevent peri-operative hypothermia as a result of increased thermogenesis (10,11) without additional sympatho-adrenal activity (12). The mechanism is based on nutrient induced thermogenesis; i.e., nutrient intake, especially proteins and amino acids, stimulates resting energy expenditure and heat production (13). This effect is more pronounced during general anesthesia than neuraxial block (14). It has also been proved that amino acid infusion before and/or during anesthesia and surgery decreases intra-operative blood loss (15), improves peri-operative recovery (16) and shortens the duration of hospital stay (17). The safety of intravenous amino acid infusion during cesarean delivery was long ago established (18,19).While maternal intravenous administration of amino-acids led to increased levels of amino acids in maternal venous blood and fetal umbilical cord blood plasma, there was no increase in fetal uptake of amino acids. The safety of amino acid in the first day of life after delivery has also already been proved (20,21). It has been used to achieve positive protein balance in the immediate postoperative period in neonates undergoing abdominal surgery (20). Aggressive therapy of intravenous amino acid in preterm infants during 12 hrs to two weeks after birth enhanced their growth and improved their nutritional status during hospitalization (21). Rationale of the study: One way to prevent the development of hypothermia during anesthesia is to stimulate endogenous heat production. Energy expenditure increases after ingestion or infusion of nutrients. The amount of energy expended over baseline, or thermic effect of food mainly represents the energy cost of nutrient absorption, handling, and storage. Among the different nutrients, proteins elicit the largest increase in energy expenditure and heat production. Previous studies have found that intravenous amino acid infusions exert enhanced thermogenic effects during general anesthesia (10) The mechanism behind this phenomenon is not fully understood, although nutrient intake stimulates energy expenditure, and hence heat production, in the awake state (13). The administration of proteins/amino acids in awake individuals results in an approximately 20% increase in whole-body heat content and a significant increase in body temperature (22,23). Since amino acid transfer across the placenta depends upon its concentration in maternal blood (21,24), the investigators hypothesize that by increasing its concentration in the maternal blood, the amino acid level in newborn will be increased. The amino acid induced increased thermogenesis in the mother is likely to increase maternal temperature and thus fetal temperature. Also amino acids that have crossed the placenta may increase thermogenesis in the fetus, further enhancing neonatal temperature. Research design and methodology: After getting approval from the institutional research ethics committee and written informed consent, this prospective randomized double blind study was conducted in the University hospital of B P Koirala Institute of Health Sciences (BPKIHS). Parturients belonging to American Society of Anesthesiologists physical status I and II scheduled for elective cesarean delivery were enrolled. Pregnancy with fetal distress, intrauterine growth retardation, congenital malformation or premature labor were excluded. With the help of computer generated random numbers, each consecutive eligible patients scheduled for cesarean delivery were assigned to one of the two groups to receive 200 ml of intravenous amino acid (Active drug) (n=38) or nutrient free standard ringers lactate solution (active comparator) (n=38) at 2 ml/kg/hr approximately one hour before spinal anesthesia. Amino acid solution used was a balanced mixture of 18 pure crystalline amino acids, eight of which are essential amino acids (Alamin SN ®, Albert D Limited, Kolkata, India). On the pre-anesthetic visit one day prior to surgery, all the patients were explained about the nature of the study and the various questions to be asked during the study. Approximately 90 minutes prior to surgery, each patient was taken to the pre-operative room inside the operation theater. Heart rate, respiratory rate, rectal temperature and SpO2 were monitored continuously and non invasive blood pressure every five minutes. To maintain blinding, all the infusion bags were covered with an opaque plastic sheet and labelled as 'infusion bag' and hanged on the infusion stand near the patient by an anesthetist not involved in the management or data collection thereafter. Intravenous infusion of amino acid solution or ringer's solution was started approximately one hour prior to spinal anesthesia after recording the baseline vital parameters. Each patient received a total of 200 ml at 2 ml/kg/min. Both the patients and the assessor were unaware of the group assignment. After one hour of infusion, each patient was transferred to the operating room. The ambient temperature of the operating room was maintained near 23°C. The monitoring of non invasive blood pressure, heart rate, respiratory rate, oxygen saturation (SpO2) and rectal temperature were continued at the same intervals. Spinal anesthesia was induced with 2 ml of 0.5% bupivacaine at L 3-4 inter-space applying aseptic precautions with the patient in the lateral position. After administration of spinal anesthesia, both groups received Ringers solution 15-20 ml/kg/hr maintained at ambient temperature via a separate venous access. All the patients were covered with a blanket, but no other heating methods were applied. Amino acid infusion were continued till the completion of 200 ml the solution contained in the infusion bag. The maternal rectal temperature were recorded before infusion (baseline), prior to spinal block, at the time of delivery, at half an one hour after spinal block, and at the end of infusion of 200 ml of study solution. At the end of surgery, each mother was asked about her perception of cold and its related discomfort on a 0-2 subjective scale (0= No perception, 1= Tolerable perception, 2=Intolerable perception). The rectal temperature and APGAR scores were assessed at 0, 5 and 10 minutes and suckling reflex at 10 minutes of the birth of baby. The occurrence of shivering and duration of hospital stay were noted for both the mother and baby. Primary outcome parameters was the neonatal rectal temperature at 0, 5 and 10 minutes after birth. Secondary outcome parameters included neonatal APGAR scores at 0, 5 and 10 minutes after birth, the number of newborn having suckling reflex; number of neonates who developed shivering within 10 minutes after birth; change in maternal rectal temperature relative to baseline at various time points during study drug infusion, maternal temperature at the time of delivery during intraoperative period; number of mothers developing cold sensation related discomfort during the intra-operative period; number of mothers who developed shivering during intra-operative period. Previous report showed that the mean rectal temperature of new born immediately after delivery following spinal anaesthesia was 37.7°C. (22) With the help of STATA, it was estimated that a sample size of 26 in each group could achieve a power of 95% to detect a difference of 0.5 °C (with common standard deviation of 0.5) in the outcome measure of new born rectal temperature, assuming type 1 error of 0.05. For the secondary outcome, the sample size was calculated using online statistical calculator G power (R) version 3.0.1. Cohen d was used to calculate the effect size based on the findings of a previous study.(14) The mean final core temperature 90 min after induction of spinal anaesthesia was 35.8 (SEM 0.1)°C in the saline group and 36.6 (0.1)°C in the amino acid group.(14) It was estimated that a sample size of 34 in each group could achieve a power of 80% to detect an effect size of 0.69 in the outcome measure of maternal core body temperature, assuming type 1 error of 0.05. We enrolled 38 patients in each group to compensate for dropout cases and shifting from normality in data distribution.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypothermia
Keywords
amino acid, cesarean delivery, hypothermia

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
76 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Amino acid
Arm Type
Experimental
Arm Description
Intravenous infusion of amino acid solution started approximately one hour prior to spinal anaesthesia after recording the baseline vital parameters. Each patient in experimental group received a total of 200 ml at 2 ml/kg/min.
Arm Title
Ringer's Lactate solution
Arm Type
Placebo Comparator
Arm Description
Intravenous infusion of Ringer's lactate solution started approximately one hour prior to spinal anaesthesia after recording the baseline vital parameters. Each patient in experimental group received a total of 200 ml at 2 ml/kg/min.
Intervention Type
Drug
Intervention Name(s)
Amino acid solution
Other Intervention Name(s)
Alamin SN ®, Albert D Limited, Kolkata, India
Intervention Description
a balanced mixture of 18 pure crystalline amino acids, eight of which are essential amino acids
Intervention Type
Drug
Intervention Name(s)
Ringer's lactate solution
Other Intervention Name(s)
RINGER LACTATE SOLUTION ALBERT DAVID
Intervention Description
200 ml of Ringer's lactate solution
Primary Outcome Measure Information:
Title
neonatal rectal temperature
Time Frame
0 min after delivery
Title
neonatal rectal temperature
Time Frame
5 min after delivery
Title
neonatal rectal temperature
Time Frame
10 min after delivery
Secondary Outcome Measure Information:
Title
APGAR score of newborn
Time Frame
0 min, 5 min, 10 min after birth
Title
number of newborn with adequate suckling reflex
Description
absent or present
Time Frame
10 min after birth
Title
scale assessing the discomfort related to cold sensation in mother
Description
0= No perception, 1= Tolerable perception, 2=Intolerable perception
Time Frame
intraoperative period during spinal anesthesia
Title
number of mothers who developed shivering
Time Frame
intraoperative period during spinal anesthesia
Title
length of hospital stay of mother
Time Frame
up to 72 hours
Title
length of hospital stay of newborn
Time Frame
up to 72 hours
Title
change in maternal rectal temperature compared to baseline
Time Frame
before infusion (baseline) and 1 hour
Title
maternal rectal temperature
Time Frame
at the time of delivery during intraoperative period (usually within 30 minutes)
Title
change in maternal rectal temperature compared to baseline
Time Frame
before infusion (baseline) and at one hour after spinal block
Title
change in maternal rectal temperature compared to baseline
Time Frame
before infusion (baseline) and at the end of infusion of 200 ml of study solution
Title
number of neonates who developed shivering
Time Frame
during the first 10 min after birth

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Parturients belonging to American Society of Anesthesiologists physical status I and II scheduled for elective cesarean delivery were enrolled. Exclusion Criteria: Pregnancy with fetal distress, intrauterine growth retardation, congenital malformation or premature labor were excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Krishna Pokharel, MD
Organizational Affiliation
B.P. Koirala Institute of Health Sciences
Official's Role
Study Chair
Facility Information:
Facility Name
B P Koirala Institute of Health Sciences
City
Dharan
State/Province
Koshi
ZIP/Postal Code
56700
Country
Nepal

12. IPD Sharing Statement

Citations:
PubMed Identifier
9180091
Citation
Sessler DI. Mild perioperative hypothermia. N Engl J Med. 1997 Jun 12;336(24):1730-7. doi: 10.1056/NEJM199706123362407. No abstract available.
Results Reference
background
PubMed Identifier
1928769
Citation
Sessler DI, Rubinstein EH, Moayeri A. Physiologic responses to mild perianesthetic hypothermia in humans. Anesthesiology. 1991 Oct;75(4):594-610. doi: 10.1097/00000542-199110000-00009.
Results Reference
background
PubMed Identifier
9087467
Citation
Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S, Beattie C. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA. 1997 Apr 9;277(14):1127-34.
Results Reference
background
PubMed Identifier
3813688
Citation
Valeri CR, Feingold H, Cassidy G, Ragno G, Khuri S, Altschule MD. Hypothermia-induced reversible platelet dysfunction. Ann Surg. 1987 Feb;205(2):175-81. doi: 10.1097/00000658-198702000-00012.
Results Reference
background
PubMed Identifier
1395660
Citation
Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med. 1992 Oct;20(10):1402-5. doi: 10.1097/00003246-199210000-00007.
Results Reference
background
PubMed Identifier
9416715
Citation
Lenhardt R, Marker E, Goll V, Tschernich H, Kurz A, Sessler DI, Narzt E, Lackner F. Mild intraoperative hypothermia prolongs postanesthetic recovery. Anesthesiology. 1997 Dec;87(6):1318-23. doi: 10.1097/00000542-199712000-00009.
Results Reference
background
PubMed Identifier
1673591
Citation
Heier T, Caldwell JE, Sessler DI, Miller RD. Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. Anesthesiology. 1991 May;74(5):815-9. doi: 10.1097/00000542-199105000-00003.
Results Reference
background
PubMed Identifier
8606715
Citation
Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med. 1996 May 9;334(19):1209-15. doi: 10.1056/NEJM199605093341901.
Results Reference
background
PubMed Identifier
8033514
Citation
Sellden E, Brundin T, Wahren J. Augmented thermic effect of amino acids under general anaesthesia: a mechanism useful for prevention of anaesthesia-induced hypothermia. Clin Sci (Lond). 1994 May;86(5):611-8. doi: 10.1042/cs0860611.
Results Reference
background
PubMed Identifier
8777102
Citation
Sellden E, Branstrom R, Brundin T. Preoperative infusion of amino acids prevents postoperative hypothermia. Br J Anaesth. 1996 Feb;76(2):227-34. doi: 10.1093/bja/76.2.227.
Results Reference
background
PubMed Identifier
10589647
Citation
Sellden E, Lindahl SG. Amino acid-induced thermogenesis reduces hypothermia during anesthesia and shortens hospital stay. Anesth Analg. 1999 Dec;89(6):1551-6. doi: 10.1097/00000539-199912000-00045.
Results Reference
background
PubMed Identifier
16831767
Citation
Jequier E. The influence of nutrient administration on energy expenditure in man. Clin Nutr. 1986 Nov;5(4):181-6. doi: 10.1016/0261-5614(86)90022-1.
Results Reference
background
PubMed Identifier
12488380
Citation
Kasai T, Nakajima Y, Matsukawa T, Ueno H, Sunaguchi M, Mizobe T. Effect of preoperative amino acid infusion on thermoregulatory response during spinal anaesthesia. Br J Anaesth. 2003 Jan;90(1):58-61.
Results Reference
background
PubMed Identifier
12456453
Citation
Widman J, Hammarqvist F, Sellden E. Amino acid infusion induces thermogenesis and reduces blood loss during hip arthroplasty under spinal anesthesia. Anesth Analg. 2002 Dec;95(6):1757-62, table of contents. doi: 10.1097/00000539-200212000-00053.
Results Reference
background
PubMed Identifier
11573589
Citation
Saitoh Y, Kaneda K, Tokunaga Y, Murakawa M. Infusion of amino acid enriched solution hastens recovery from neuromuscular block caused by vecuronium. Br J Anaesth. 2001 Jun;86(6):814-21. doi: 10.1093/bja/86.6.814.
Results Reference
background
PubMed Identifier
8070785
Citation
Xing A, Wan B, Zeng W. [Biochemical effects of maternal intravenous and intra-amniotic infusion of amino-acids on fetal blood]. Hua Xi Yi Ke Da Xue Xue Bao. 1994 Mar;25(1):98-102. Chinese.
Results Reference
background
PubMed Identifier
10454703
Citation
Ronzoni S, Marconi AM, Cetin I, Paolini CL, Teng C, Pardi G, Battaglia FC. Umbilical amino acid uptake at increasing maternal amino acid concentrations: effect of a maternal amino acid infusate. Am J Obstet Gynecol. 1999 Aug;181(2):477-83. doi: 10.1016/s0002-9378(99)70581-8.
Results Reference
background
PubMed Identifier
18154902
Citation
Reynolds RM, Bass KD, Thureen PJ. Achieving positive protein balance in the immediate postoperative period in neonates undergoing abdominal surgery. J Pediatr. 2008 Jan;152(1):63-7. doi: 10.1016/j.jpeds.2007.05.042. Epub 2007 Sep 17.
Results Reference
background
PubMed Identifier
22321185
Citation
Wang C, Han LY, Zhang LJ, Wang DH. [Effect of aggressive nutritional support on preterm infants during hospitalization]. Zhonghua Er Ke Za Zhi. 2011 Oct;49(10):771-5. Chinese.
Results Reference
background
PubMed Identifier
8177052
Citation
Brundin T, Wahren J. Influence of protein ingestion on human splanchnic and whole-body oxygen consumption, blood flow, and blood temperature. Metabolism. 1994 May;43(5):626-32. doi: 10.1016/0026-0495(94)90206-2.
Results Reference
background
PubMed Identifier
8166259
Citation
Brundin T, Wahren J. Effects of i.v. amino acids on human splanchnic and whole body oxygen consumption, blood flow, and blood temperatures. Am J Physiol. 1994 Mar;266(3 Pt 1):E396-402. doi: 10.1152/ajpendo.1994.266.3.E396.
Results Reference
background
PubMed Identifier
12583600
Citation
Regnault TR, de Vrijer B, Battaglia FC. Transport and metabolism of amino acids in placenta. Endocrine. 2002 Oct;19(1):23-41. doi: 10.1385/ENDO:19:1:23.
Results Reference
background
PubMed Identifier
16700681
Citation
Fallis WM, Hamelin K, Symonds J, Wang X. Maternal and newborn outcomes related to maternal warming during cesarean delivery. J Obstet Gynecol Neonatal Nurs. 2006 May-Jun;35(3):324-31. doi: 10.1111/j.1552-6909.2006.00052.x.
Results Reference
background
PubMed Identifier
33789610
Citation
Pokharel K, Subedi A, Tripathi M, Biswas BK. Effect of amino acid infusion during cesarean delivery on newborn temperature: a randomized controlled trial. BMC Pregnancy Childbirth. 2021 Mar 31;21(1):267. doi: 10.1186/s12884-021-03734-4.
Results Reference
derived

Learn more about this trial

Amino Acid Infusion in Mothers Before and During Cesarean Delivery

We'll reach out to this number within 24 hrs